top-lin result higher expens led miss adj ep
come consensu takeaway includ number
time item skew result includ non-recur return reserv
higher spend anthem-hf trial arent worri sale
slippag percev moder expect tandemlif
ramp trend may continu bear monitor view
watch wait decis depress coverag
didnt learn anyth new surprisingli balanc dont believ
result disappoint appear surfac continu
out-performance all-import neuromod segment replac
tailwind within heart lung machin howev management signal
canadian busi exit variabl around percev
tandem feel lot ride success acceler within neuromod
maintain stock momentum premium valuat feel
appropri maintain neutral rate factor risk particularli
around trd dont better opinion today may
decid management seem work would tip hand
percev hit speed bump quarter unexpect surpris
lacklust percev sale especi post double-digit sale
last quarter management attribut weak intern
issu oppos cede share posit management commit
resolv issu fortifi sale leadership said
feel valv space crowd move cathet
tweak forecast ramp oper spend surpass
expect feel disloc sale
side heart valv tandemlif like keep expens elev
time without trd opportun though
optimist trend within cardiopulmonari neuromod
trim forecast oem exit tandemlif
valuat maintain neutral risk page
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
consolid revenu total come lower
street-conserv revenu estim biggest area downsid came
heart valv busi result hurt weaker percev sale
non-recur return reserv worth relat busi
y/i buoy heart-lung machin revenu growth mid-singl
digit double-digit europ oxygen improv
high-singl digit auto-transfus momentum percev sale grew
high-singl digit manag see soft eu
turn neuromod result better expect growth
back double-digit growth initi implant high-singl digit
growth end-of-servic implant sentiva account
gener sale report last quarter europ
neuromod growth benefit launch sentiva final
mention previous rest word neuromod sale improv result
chang busi model key market like japan latin america
adjust gross margin fairli close forecast howev sg
margin meaning higher impact fx
higher sg spend also driven higher dtc spend
sale support invest spend revenu
higher compani need invest ahead anthem-hf trial
non-gaap oper margin weaker forecast adj
ep vs consensu lower tax rate slightli offset
actualsbtig estimate varianceconsolid surgeri good oper minor tax tax btig estim compani filingsal item million except per-shar percentag amountsal item present non-gaap basi exclud item varianc
make hand chang tweak neuromod estim
upsid decreas tandemlif estim go forward
trim heart valv forecast margin assum flattish sg dollar
elev spend stay conserv new adj ep
move reflect downsid
also tweak tandemlif forecast remov due
oem busi exit canada cardiopulmonari segment
up heart-lung machin sale forecast quarter feel
durabl pipelin convers origin perceiv
also lift neuromod forecast better trend ytd margin
trim estim incorpor higher sg also lower
tax rate mirror trend seen
rate neutral price-to-earnings basi share trade mani
livn peer large-cap mid-cap grow revenu similar place
altern share also trade mid cap name feel
grow faster long term split differ see hypothet pt close
share trade today think immedi accret
growth market could serv catalyst stock feel quit
bit good news price depress reaffirm coverag
decis could big disappoint btig provid price
target neutral-r stock
risk rate includ missing/b guidanc declin surgic avr
volum slow vn new patient growth competit issu fda
trials/develop unsuccess bid medicar coverag vn
growth btig estim compani filingsnewold chang
ntm capjohnson johnsonjnjund bdxnot scientificbsxbuy cap capresmedrmdnot medicalwmginot cap factset data btig estimatesintra-day price ex-amortev/salescagrcompanytickr ptpricemarket cap
-- -- -- -- -- -- restat divestitur -- -- -- -- -- -- -- non-gaap incom good sold oper incom continu incom continu minor tax expens net share oper pre-tax net net net net oper calcul effect tax calcul effect tax btig estim compani reportsfor quarter tax-effect earn use tax rate deriv ep comparison purpos
-- -- -- -- -- -- restat divestitur -- -- -- -- -- -- -- consolid million machin includ report cc report cc system report cc report cc report cc heart report cc heart valv includ sutureless report cc report cc report cc sorin btig estim compani note sub-seg within cardiopulmonari heart valv cardiac rhythm repres btig estim actual result attempt estim line item base histor provid sorin prior merger go-forward basi compani disclosur
